Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854081 · ClinicalTrials.gov registry record
EluPro Antibiotic-Eluting BioEnvelope Registry
A clinical trial of Cardiac Arrhythmias, sponsored by Elutia.
- Recruiting
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT06854081: Recruiting study of Cardiac Arrhythmias, sponsored by Elutia.
NCT06854081 is a study of Cardiac Arrhythmias that is actively recruiting participants, run by Elutia. The registered enrollment target is 100 participants, below the 522-participant average among 5 other Cardiac Arrhythmias trials with a reported enrollment target (81% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06854081, a study of Cardiac Arrhythmias, is actively recruiting participants, sponsored by Elutia.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
A Multi-Center Registry Study Evaluating Participants Who Receive EluPro Antibiotic-Eluting BioEnvelope During CIED Implantation
Primary Outcome
Determine the rates of adverse events and complications associated with the use of EluPro device envelope in real-world settings.
Conditions Studied
Interventions
- COMBINATION_PRODUCT EluPro Antibiotic-Eluting BioEnvelope
Study Locations (4)
California
- UC San Diego Health - La Jolla
Florida
- Tallahassee Research Institute - Tallahassee
Massachusetts
- Brigham & Women's Hospital - Boston
Pennsylvania
- Penn Presbyterian Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-04-17 |
| Est. Completion | 2026-12 |
What NCT06854081 shows while recruiting
NCT06854081 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 522-participant average among 5 other Cardiac Arrhythmias trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cardiac Arrhythmias appearing as the primary indexed condition, and to 1 intervention - of which EluPro Antibiotic-Eluting BioEnvelope is the first listed.
NCT06854081 reports a single indexed study location in California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06854081 about?
NCT06854081 is a clinical study titled "EluPro Antibiotic-Eluting BioEnvelope Registry". A Multi-Center Registry Study Evaluating Participants Who Receive EluPro Antibiotic-Eluting BioEnvelope During CIED Implantation
What is the current status of trial NCT06854081?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-04-17. Estimated completion is 2026-12.
What conditions does trial NCT06854081 study?
This clinical trial studies the following conditions: Cardiac Arrhythmias.
What interventions are being tested in trial NCT06854081?
The interventions under investigation include: EluPro Antibiotic-Eluting BioEnvelope (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06854081?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06854081 being conducted?
This trial has 4 study locations across California, Florida, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RECRUITING
-
ViewFlex X ICE First-in-Human Study
RECRUITING
-
Confirm Rx Insertable Cardiac Monitor SMART Registry
ACTIVE NOT RECRUITING
-
Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
COMPLETED
-
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI